Legal Battle Unfolds
LOS ANGELES, Sept. 13, 2024 — Glancy Prongay & Murray LLP (“GPM”) unveils a rare opportunity for investors who have sustained substantial losses. They now have the chance to spearhead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) under the ticker symbol OM.
Key Details and Timeline
Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024
Allegations and Implications
The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose critical information to investors. From marketing products without FDA approval to potential risks associated with sales, a series of omissions led to misleading statements that jeopardized the Company’s credibility.
Community Engagement
For individuals eager to serve as lead plaintiff or seek further information about the Outset Medical lawsuit, details are available. Contact Charles H. Linehan of GPM via phone at 310-201-9150, Toll-Free at 888-773-9224, or email at shareholders@glancylaw.com for clarity on your rights.
Standing Strong
As the legal saga unfolds, individuals keen on partaking in the class action need not take immediate action. Whether retaining personal counsel or choosing to remain an observer, options abound. For detailed inquiries, connect with experts or visit the dedicated website for comprehensive information.
Final Considerations
In the realms of law and ethics, adverts, and engagements must align with jurisdiction-specific norms. Therefore, comprehensive outreach is imperative for all stakeholders. For additional information or assistance, do not hesitate to reach out to the legal representatives at GPM.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
View original content to download multimedia:
Read more
SOURCE Glancy Prongay & Murray LLP
